Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Heparin cofactor")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 136

  • Page / 6
Export

Selection :

  • and

Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfateFABIANA ALBERTO, Maria; GIAQUINTA ROMERO, Diego; LAZZARI, Maria et al.Thrombosis research. 2008, Vol 122, Num 1, pp 109-116, issn 0049-3848, 8 p.Article

The medicinal plant Porana volubilis contains polysaccharides with anticoagulant activity mediated by heparin cofactor IIYOON, Seon-Joo; PEREIRA, Mariana S; PAVAO, Mauro S. G et al.Thrombosis research. 2002, Vol 106, Num 1, pp 51-58, issn 0049-3848Article

Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula)MOHAMED BEN MANSOUR; DHAHRI, Manel; BERTHOLON, Isabelle et al.Thrombosis research. 2009, Vol 123, Num 6, pp 887-894, issn 0049-3848, 8 p.Article

A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement proteinCALABRESE, Graciela C; ALBERTO, Maria F; TUBIO, Rosario et al.Thrombosis research. 2004, Vol 113, Num 3-4, pp 243-250, issn 0049-3848, 8 p.Article

Activation of heparin cofactor II by heparin and dermatan sulfateTOLLEFSEN, D. M.Nouvelle revue française d'hématologie. 1984, Vol 26, Num 4, pp 233-237, issn 0029-4810Article

Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfateMOHAMED BEN MANSOUR; DHAHRI, Manel; VENISSE, Laurence et al.Thrombosis research. 2009, Vol 123, Num 6, pp 902-908, issn 0049-3848, 7 p.Article

Heparin cofactor II is more sensitive than antithrombin to secretory impairment arising from mutations introduced into its carboxy-terminal regionBHAKTA, Varsha; BEGBIE, Megan E; GUPTA, Anjalee et al.Thrombosis research. 2004, Vol 113, Num 2, pp 163-173, issn 0049-3848, 11 p.Article

Anticoagulant and anti-platelet activity of polyphenolic-polysaccharide preparation isolated from the medicinal plant Erigeron canadensis LPAWLACZYK, Izabela; CZERCHAWSKI, Leszek; KULICZKOWSKI, Wiktor et al.Thrombosis research. 2011, Vol 127, Num 4, pp 328-340, issn 0049-3848, 13 p.Article

Purififation and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycansYAMAGISHI, R; NIWA, M; KONDO, S et al.Thrombosis research. 1984, Vol 36, Num 6, pp 633-642, issn 0049-3848Article

Combined inherited protein S and heparin co-factor II deficiency in a patient with upper limb thrombosis : a family studySIMIONI, P; ZANARDI, S; PRANDONI, P et al.Thrombosis research. 1992, Vol 67, Num 1, pp 23-30, issn 0049-3848Article

The N-terminal acidic domain of heparin cofactor II mediates the inhibition of α-thrombin in the presence of glycosaminoglycansVAN DEERLIN, V. M. D; TOLLEFSEN, D. M.The Journal of biological chemistry (Print). 1991, Vol 266, Num 30, pp 20223-20231, issn 0021-9258Article

Heparin cofactor II in adults and infants with thrombosis and DICCHUANSUMRIT, A; MANCO-JOHNSON, M. J; HATHAWAY, W. E et al.American journal of hematology. 1989, Vol 31, Num 2, pp 109-113, issn 0361-8609Article

HEPARIN COFACTOR ACTIVITY FOLLOWING THERMAL INJURYBRAUNSTEIN KM; DODDS KA; STEWART G et al.1978; AMER. J. CLIN. PATHOL.; USA; DA. 1978; VOL. 70; NO 4; PP. 632-636; BIBL. 16 REF.Article

Investigating serpin : enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor IISUTHERLAND, Jason S; BHAKTA, Varsha; SHEFFIELD, William P et al.Thrombosis research. 2006, Vol 117, Num 4, pp 447-461, issn 0049-3848, 15 p.Article

Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor IICOOPER, Scott T; REZAIE, Alireza R; ESMON, Charles T et al.Thrombosis research. 2002, Vol 107, Num 1-2, pp 67-73, issn 0049-3848, 7 p.Article

Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) studyRAU, Jill C; DEANS, Carolyn; HOFFMAN, Maureane R et al.Experimental and molecular pathology. 2009, Vol 87, Num 3, pp 178-183, issn 0014-4800, 6 p.Article

Isolation of frog and chicken cDNAs encoding heparin cofactor IICOLWELL, N. S; TOLLEFSEN, D. M.Thrombosis and haemostasis. 1998, Vol 80, Num 5, pp 784-790, issn 0340-6245Article

A CATALYTIC ROLE FOR HEPARIN. EVIDENCE FOR A TERNARY COMPLEX OF HEPARIN COFACTOR THROMBIN AND HEPARINPOMERANTZ MW; OWEN WG.1978; BIOCHIM. BIOPHYS. ACTA; NLD; DA. 1978; VOL. 535; NO 1; PP. 66-77; BIBL. 25 REF.Article

Heparin cofactor II modulates the response to vascular injuryTOLLEFSEN, Douglas M.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 3, pp 454-460, issn 1079-5642, 7 p.Article

High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stentingSCHILLINGER, Martin; EXNER, Markus; SABETI, Schila et al.Thrombosis and haemostasis. 2004, Vol 92, Num 5, pp 1108-1113, issn 0340-6245, 6 p.Article

Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitorsTAKETOMI, Taro; SZLAM, Fania; VINTEN-JOHANSEN, Jakob et al.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 8, pp 761-767, issn 0957-5235, 7 p.Article

Synthesis of a dermatan sulphate-like hexasacharide with a non-glycosamino glycan structureBASTEN, J. E. M; VAN BOECKEL, C. A. A; JAURAND, G et al.Bioorganic & medicinal chemistry letters (Print). 1994, Vol 4, Num 7, pp 893-898, issn 0960-894XArticle

Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analoguesJESKE, W; JAWED FAREED.Seminars in thrombosis and hemostasis. 1993, Vol 19, pp 241-247, issn 0094-6176, SUP1Article

Use of purified dermatan sulfate for heparin cofactor II (HC II) assayRUZZENENTE, O; GHIDINI, R; POLI, G et al.Thrombosis research. 1992, Vol 65, Num 2, pp 281-287, issn 0049-3848Article

Heparin cofactor II deficiency in renal allograft recipients : no correlation with the development of thrombosisTOULON, P; MOULONGUET-DOLERIS, L; COSTA, J. M et al.Thrombosis and haemostasis. 1991, Vol 65, Num 1, pp 20-24, issn 0340-6245Article

  • Page / 6